| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2004-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d43506a6162fe3f0a54cc6fc092949d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_527f2821bccdebb7dfd366d1cbce1b0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b15420752d6e7631cc7a46e294bc20b |
| publicationDate |
2006-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1646874-A1 |
| titleOfInvention |
A method for predicting the metastatic potential of breast cancer |
| abstract |
A process for determining whether a tumor sample has potential for tumor progression is provided whereby the overexpression of four genes, transmembrane receptor tyrosine kinase DDR2, transmembrane receptors PMP22 and EMP3 and cell adhesion molecule N-cadherin in a sample is analyzed. Kits suitable for performing the invention are also provided. Methods for deriving a candidate agent are also disclosed. |
| priorityDate |
2003-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |